- Corporate Officers - B
- Burgstahler David F
Insider Trading History of Burgstahler David F
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Burgstahler David F since 2007.
The trader's CIK number is 1374179.
At the time of the last reporting, Burgstahler David F was the Officer of Organogenesis Holdings Inc.. (stock ticker symbol ORGO).
Also see all insider trading activities at Organogenesis Holdings Inc..
Note that in the past
Burgstahler David F also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Syneos Health, Inc. (INCR) by Burgstahler David F
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | INCR | 1,000 | $43,187 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Organogenesis Holdings Inc. (ORGO) by Burgstahler David F
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | ORGO | 4,949,350 | $19,218,803 | 0 | $0 | 0 | $0 |
| 2019 | ORGO | 7,975,500 | $40,735,842 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Angiodynamics Inc (ANGO) by Burgstahler David F
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | ANGO | 0 | $0 | 2,350,000 | $37,600,000 | 0 | $0 |
| 2016 | ANGO | 0 | $0 | 4,341,294 | $65,686,489 | 0 | $0 |
Yearly summary of insider trading at Warner Chilcott Ltd (WCRX) by Burgstahler David F
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | WCRX | 10,000 | $156,500 | 0 | $0 | 0 | $0 |
| 2007 | WCRX | 10,000 | $147,700 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Osmotica Pharmaceuticals Plc (OSMT) by Burgstahler David F
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | OSMT | 1,250,000 | $6,250,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Lantheus Holdings, Inc. (LNTH) by Burgstahler David F
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | LNTH | 0 | $0 | 9,644,488 | $132,438,274 | 0 | $0 |
| 2016 | LNTH | 0 | $0 | 2,500,000 | $22,500,000 | 0 | $0 |
Insider trading activities at 6 companies by Burgstahler David F:
1. Syneos Health, Inc. (INCR)
2. Organogenesis Holdings Inc. (ORGO)
3. Angiodynamics Inc (ANGO)
4. Warner Chilcott Ltd (WCRX)
5. Osmotica Pharmaceuticals Plc (OSMT)
6. Lantheus Holdings, Inc. (LNTH)
Table 1. Insider trading of Syneos Health, Inc. (INCR) by Burgstahler David F
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-09-19 | INCR | Buy | 1,000 | 43.19 | 43,187 |
Table 2. Insider trading of Organogenesis Holdings Inc. (ORGO) by Burgstahler David F
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-11-24 | ORGO | Buy | 100 | 5.00 | 500 |
| 2020-11-20 | ORGO | Buy | 2,739 | 4.99 | 13,670 |
| 2020-11-17 | ORGO | Buy | 4,322,657 | 3.85 | 16,637,906 |
| 2020-11-18 | ORGO | Buy | 45,378 | 4.68 | 212,505 |
| 2020-11-19 | ORGO | Buy | 36,127 | 4.97 | 179,623 |
| 2020-03-16 | ORGO | Buy | 75,000 | 3.98 | 298,125 |
| 2020-03-13 | ORGO | Buy | 135,000 | 4.31 | 581,310 |
| 2020-03-12 | ORGO | Buy | 332,349 | 3.90 | 1,295,164 |
| 2019-11-26 | ORGO | Buy | 6,000,000 | 5.00 | 30,000,000 |
| 2019-09-12 | ORGO | Buy | 413,900 | 6.25 | 2,585,219 |
| 2019-09-11 | ORGO | Buy | 447,000 | 5.75 | 2,570,250 |
| 2019-09-06 | ORGO | Buy | 500,000 | 5.18 | 2,592,500 |
| 2019-09-09 | ORGO | Buy | 25,000 | 5.12 | 128,025 |
| 2019-09-10 | ORGO | Buy | 12,000 | 5.18 | 62,208 |
| 2019-09-03 | ORGO | Buy | 200,000 | 4.75 | 949,799 |
| 2019-09-04 | ORGO | Buy | 200,000 | 4.90 | 979,200 |
| 2019-09-05 | ORGO | Buy | 177,600 | 4.89 | 868,641 |
Table 3. Insider trading of Angiodynamics Inc (ANGO) by Burgstahler David F
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-04-12 | ANGO | Sale | 2,350,000 | 16.00 | 37,600,000 |
| 2016-11-18 | ANGO | Sale | 2,091,294 | 15.68 | 32,791,489 |
| 2016-08-05 | ANGO | Sale | 2,250,000 | 14.62 | 32,895,000 |
Table 4. Insider trading of Warner Chilcott Ltd (WCRX) by Burgstahler David F
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-03-07 | WCRX | Buy | 10,000 | 15.65 | 156,500 |
| 2007-03-12 | WCRX | Buy | 10,000 | 14.77 | 147,700 |
Table 5. Insider trading of Osmotica Pharmaceuticals Plc (OSMT) by Burgstahler David F
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-01-13 | OSMT | Buy | 1,250,000 | 5.00 | 6,250,000 |
Table 6. Insider trading of Lantheus Holdings, Inc. (LNTH) by Burgstahler David F
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-09-07 | LNTH | Sale | 102,958 | 16.56 | 1,704,984 |
| 2017-09-01 | LNTH | Sale | 6,000 | 17.10 | 102,600 |
| 2017-09-05 | LNTH | Sale | 52,010 | 17.08 | 888,330 |
| 2017-09-06 | LNTH | Sale | 20,823 | 16.59 | 345,453 |
| 2017-08-29 | LNTH | Sale | 20,653 | 17.02 | 351,514 |
| 2017-08-30 | LNTH | Sale | 58,031 | 17.05 | 989,428 |
| 2017-08-31 | LNTH | Sale | 152,001 | 17.36 | 2,638,737 |
| 2017-08-25 | LNTH | Sale | 42,276 | 17.01 | 719,114 |
| 2017-08-28 | LNTH | Sale | 28,890 | 17.01 | 491,361 |
| 2017-08-24 | LNTH | Sale | 20,000 | 17.02 | 340,400 |
| 2017-08-16 | LNTH | Sale | 12,128 | 17.05 | 206,782 |
| 2017-08-15 | LNTH | Sale | 40,779 | 17.06 | 695,689 |
| 2017-08-14 | LNTH | Sale | 87,939 | 17.67 | 1,553,882 |
| 2017-06-20 | LNTH | Sale | 3,000,000 | 14.87 | 44,610,000 |
| 2017-05-09 | LNTH | Sale | 3,000,000 | 13.40 | 40,200,000 |
| 2017-03-17 | LNTH | Sale | 3,000,000 | 12.20 | 36,600,000 |
| 2016-11-21 | LNTH | Sale | 2,500,000 | 9.00 | 22,500,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Burgstahler David F
(Officer of Organogenesis Holdings Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.